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Abstract: This study, designed to investigate
the blood lactate and pyruvate levels in AMI,
was carried out on 41 patients. Based upon
the localization of AMI, the patients were
studied under anterior AMI (n=17), anteroseptal AMI (n=9) and inferior AMI (n=15)
groups. Left ventricular failure developed in
five patients with anterior AMI and in one patient with anteroseptal AMI. Cardiogenic
shock developed in two patients with anterior
AMI. Lactate and pyruvate were analysed in
the blood samples drawn 24-48 hours after
AMI. CPK, CPK-MB, AST and LDH activities
were determined in the sera of blood samples
drawn within 6-24 hours of AMI. Enzymatic
methods were performed for lactate and pyruvate analyses, kinetic methods of CPK and
LDH activities, immunoassay for CPK-MB and
colorimetric method for AST.
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Introduction
Cardiogenic shock is a leading cause of death in
patients with acute myocardial infarction (AMI). In a
patient with AMI and left ventricular failure, development of lactic acidosis prognosticates a poor outcome.
Elevation of lactate level occurs when oxygen delivery
to the nutrient capillaries falls below a critical value to
maintain cellular aerobic metabolism. Increased metabolic demands, when not met by an increase in cardiac
output and oxygen extractions, are associated with the
development of lactic acidosis (1,2). Patients with AMI
and left ventricular failure are not able to increase
cardiac output, especially when exposed to metabolic
stress leading to an additional increase in lactic acidosis.
Blood lactate has been suggested to predict shock
development in AMI and also serves as a prognostic
marker for risk of recurrent cardiac arrest and cardiovascular mortality (3, 4).

A significant difference was found between
the pyruvate values of anterior and anteroseptal AMI groups and also between anterior and inferior AMI groups (0.05>p>0.02,
0.02>p0.01 respectively) Lactate/pyruvate
ratio was found to be significantly higher in
the anterior AMI group in comparison to the
inferior AMI group (0.05>p>0.02). The cardiac enzyme activities were found to be significantly higher in the anterior AMI group.
Increased blood lactate/pyruvate ratio might
be considered as a predictor of left ventricular failure and shock occurence in AMI
and also as an indicator of insufficient tissue
oxygenation, might serve as a determinant in
choosing the correct intervention therapy.
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In this study, we aimed to evaluate the predictory
importance of both lactate and, its only known precursor, pyruvate in AMI with different localizations.
Materials and Methods
The study was carried out on 41 patient diagnosed
as AMI. The diagnosis of AMI was based on the presence of 2 or more of the following criteria: Characteristic history of prolonged chest pain, elevation in serial
cardiac enzymes and characteristic electrocardiographic
ST-T changes with or without development of new q
waves. In the presence of only ST-T changes on electrocardiogram, elevation of cardiac enzymes was required for confirmation of AMI.
Based upon the electrocardiographic localization of
AMI, the patients were grouped as:
Anterior AMI (n=17) (age: 56.12±14.87)
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Anteroseptal AMI (n=9) (age: 61.22±11.24)
Inferior AMI (n=15) (age: 57.80±11.98)
Clinical symptoms of left ventricular failure (dyspnea, nocturia, tachycardia, third heart sound, rales in
the lungs) were observed in 5 patients with anterior
AMI and in 1 patient with anteroseptal AMI. Cardiogenic shock (defined as systolic blood pressure <90
mmHg accompanied by the clinical signs of peripheral
hypoperfusion and a decrease in urinary output <20
ml/hr) developed in 2 patients with anterior AMI. Neither left ventricular failure nor cardiogenic shock was
observed in patients with inferior AMI.
To determine lactate and pyruvate concentrations,
fasting venous blood samples were drawn from a brachial vein, without the use of a tourniquet, 24-28
hours after AMI, the time period accepted critical for
the development of left ventricular failure.
Creatine phosphokinase (CPK), creatine phosphokinase MB (CPK-MB), lactate dehydrogenase (LDH)
and aspartate amino transferase (AST) activities were
determined in the sera of blood samples drawn within
the first 6-24 hours of AMI.
Enzymatic methods were performed for lactate and
pyruvate analyses, kinetic methods for CPK and LDH
activities, immunoassay for CPK-MB and colorimetric
method for AST.
Statistics:
Results are expressed as mean ± SD. Statistical significance between the groups is determined by Student’s "t” test.
Results
Values and statistical comparison of the analysed parameters in patients with AMI are shown in Table 1.
Table 1.

Values and statistical
parameters in AMI
Anterior
AMI
(n=17)

Lactate (mg/dl)
Pyruvate (mg/dl)
L/P
CPK-MB (U/L)
CPK (U/L)
LDH (U/L)
AST (U/L)

15.76±8.09
0.58±0.24
36.55±24.20
106.24±27.14
1620.06±1582.68
1160.53±771.58
242.65±169.32

a: Anterior AMI vs Anteroseptal AMI
b: Anterior AMI vs Inferior AMI
c: Anteroseptal AMI vs inferior AMI
* p <0.05, ** p<0.01, *** p<0.001
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comparison

Anteroseptal
AMI
(n=9)

of

the

analysed

Inferior
AMI
(n=15)

12.39±3.65
14.92±5.00
1.04±0.88a*
1.31±0.92b**
22.63±22.112
21.37±18.42b*
85.44±47.13
68.07±40.31b**
1058.11±792.35c** 441.33±377.44b**
1184.54±427.42c*
379±112.33b***
162.67±144.02
88.40±41.92b**

A significant difference was found between the pyruvate values of anterior and anteroseptal AMI groups
and also between anterior and inferior AMI groups
and also between anterior and inferior AMI groups
(0.05>p>0.02, 0.02>p>0.01 respectively) Lactate/
pyruvate ratio was found to be significantly higher in
the anterior AMI group in comparison to the inferior
AMI group (0.05>p>0.02). The cardiac enzyme activities were found to be significantly higher in the anterior AMI group.
Discussion
In states of tissue hypoperfusion and resultant tissue hypoxia the mitochondrial pathways cease to generate energy. In an attempt to satisfy the energy
needs of the organism pyruvate-lactate shunt is activated as an emergency pathway of anaerobic metabolism. Thus, blood lactate and pyruvate values gain
importance in the detection of impaired oxygenation in
critical care patients. These values reflect the cumulative oxygen deficit and serve as a close correlate
of survival (5, 6, 7).
In the presented study we measured blood pyruvate and lactate concentrations in patients with
acute myocardial infarction of different localizations.
The blood pyruvate concentration was found to be
significantly lower in the anterior AMI group when
compared to both anteroseptal (0.5±0.24 vs
1.0±0.88, 0.00>p>0.02) and inferior (0.58±0.24 vs
1.31±0.92, 0.02>p>0.01) AMI groups. Higher blood
lactate concentration of the anterior AMI group, however did not show significance in comparison.
Lactate/Pyruvate ratio was found to be significantly
higher in the anterior AMI group in comparison to the
inferior AMI group (0.05>p>0.02). This finding suggests a greater oxygen deficit and a higher possibility
for the development of left ventricular failure and cardiogenic shock in anterior AMI patients than in the anteroseptal and inferior AMI patients. Supporting the
above suggestion, clinical symptoms of left ventricular
failure were observed in 5 patients with anterior AMI
(5/17: 30%) whereas only in 1 patient with anteroseptal AMI (1/9: 17%) and in none of the patients
with inferior AMI. Moreover, cardiac specific enzymes
were found to be higher specifically in the anterior
AMI patients.
Hands et al (8) focused specifically on the need of a
an index as a prediction of shock development in patients with AMI. Such an index would be of great utility
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if it is based on simple clinical and laboratory findings
that are readily available for every patient. The value of
peripheral blood lactate concentration as prognostic
marker for risk of recurrent cardiac arrest has been
demonstrated by Sheps (9) and Kessler et al (2).
According to our data however, there appears to
be a higher possibility for the development of cardiogenic shock when anterior AMI presents itself not
only with an increase in lactate and lactate/pyruvate
ratio but also with a decrease in pyruvate level. Especially in clinical setting, the analyses of lactate and
pyruvate, performed with technical ease and rapidity
would offer the clinician an objective measure for both
the presence and the severity of the shock state and
would aid in choosing the right intervention therapy.
The effectiveness of the applied therapy may best be
gauged by repetitive measurements of L/P ratio (10,
11, 12, 13).

We conclude that, the concentrations of lactate and
pyruvate in blood, and more specifically their ratio are
good indicators of oxygen deficit and tissue oxygenation. Lactate/Pyruvate ratio is found to be increased to a higher extent in patients with acute anterior myocardial infarction, with a higher risk for tissue
hypooxygenation, left ventricular failure and cardiogenic shock than in patients with inferior myocardial infarction. The measurement of both pyruvate and lactate may thus provide practical cilinical usefulness and
early assessment of critically ill AMI patients.
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